BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4949673)

  • 1. [Clinical study of 47 patients with stomach cancer treated with mitomycin C].
    Paolucci R
    Cancro; 1971; 24(3):153-9. PubMed ID: 4949673
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitomycin (Mutamycin).
    Med Lett Drugs Ther; 1975 Jul; 17(15):62-3. PubMed ID: 50555
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutics: mitomycin C: a brief review.
    Reich SD
    Cancer Nurs; 1982 Apr; 5(2):152-4. PubMed ID: 6804088
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined application of drugs in cancer chemotherapy with special reference to the combination of mitomycin C, 5-fluorouracil, and cytosine arabinoside].
    Nakao I; Furue H; Furukawa K; Kanko T; Harashima S
    Gan No Rinsho; 1972 Feb; 18(2):138-43. PubMed ID: 5063156
    [No Abstract]   [Full Text] [Related]  

  • 5. [Future expectations for the study of cancer].
    Kuru M
    Nihon Ishikai Zasshi; 1968 Jun; 59(11):1457-78. PubMed ID: 4883342
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with mitomycin C (NSC-26980).
    Whittington RM; Close HP
    Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of advanced gastric cancer with 5-fluorouracil versus mitomycin C.
    Gupta S
    J Surg Oncol; 1982 Oct; 21(2):94-6. PubMed ID: 6752585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
    Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Ikeda K; Usui N; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1160-4. PubMed ID: 6408998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up study on gastric cancer treated with mitomycin C prior to surgical operation.
    Sakakibara N; Okajima K; Okumura S
    Acta Med Okayama (1952); 1966 Aug; 20(4):175-9. PubMed ID: 4226978
    [No Abstract]   [Full Text] [Related]  

  • 12. [A study on the preoperative administration of anticancer drug (mitomycin C) against gastric cancer (author's transl)].
    Ichioka G
    Nihon Geka Hokan; 1974 Mar; 43(2):124-45. PubMed ID: 4473149
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on preoperative cancer chemotherapy. Effects of preoperative intra-arterial infusion of methotrexate and mitomycin C on stomach cancer.
    Fujimoto S; Urushibara O; Watanabe Y; Miyoshi T; Adachi M
    Jpn J Surg; 1971 Mar; 1(1):72-82. PubMed ID: 4950886
    [No Abstract]   [Full Text] [Related]  

  • 14. [Administration of mitomycin-C with an inactivator].
    Takahashi M; Yoshida K
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):525-7. PubMed ID: 3932560
    [No Abstract]   [Full Text] [Related]  

  • 15. Intratumoral treatment of pancreatic cancer with mitomycin-C adsorbed to activated carbon particles. A clinical trial on 15 cases.
    Moriai T; Makino TT; Ishii K
    Anticancer Res; 1989; 9(6):1799-804. PubMed ID: 2516716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dosage and its safety in intraperitoneal high dose mitomycin C administration as postoperative adjuvant therapy for gastric cancer].
    Hiratsuka M; Ogawa A; Ohigashi H; Kameyama M; Sasaki Y; Ishikawa O; Kabuto T; Fukuda I; Furukawa H; Imaoka S
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1574-9. PubMed ID: 3141534
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.
    Haas CD; Mansfield CM; Leichman LP; Considine B; Bukowski RM
    Cancer Treat Rep; 1983 May; 67(5):421-4. PubMed ID: 6687837
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy of stomach cancer-with special reference to massive and intermittent administration of mitomycin C].
    Matsunaga F; Shimoyama T; Mikawa K; Ishiwata J; Kikuchi H
    Naika; 1966 Jun; 17(6):1101-15. PubMed ID: 5964528
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of factors affecting clinical cancer chemotherapy].
    Wakui A; Taguchi T
    Gan No Rinsho; 1983 Aug; 29(10):1199-204. PubMed ID: 6415312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers].
    Nishi I; Yokoyama T; Nakao I; Harashima S; Ohashi Y; Kanko T; Saito T
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2513-9. PubMed ID: 6508315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.